Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Test Differentiates Lyme Disease from Similar Condition

By LabMedica International staff writers
Posted on 29 Aug 2017
Lyme disease is the most commonly reported vector-borne illness in the USA, and current laboratory tests are not sensitive enough to detect infection with high accuracy in the first few weeks of illness. More...
In 2015, 95% of confirmed Lyme disease cases were reported from 14 US states.

Southern Tick-Associated Rash Illness (STARI) which is characterized by a rash indistinguishable from that of Lyme disease and by possible fatigue, fever, headache, and muscle pains. The current laboratory test used for Lyme disease also cannot diagnose STARI, for which the cause is unknown.

Lyme disease is transmitted when blacklegged ticks infected with the bacterium Borrelia burgdorferi bite people, while Lone star ticks, which cause STARI, do not transmit B. burgdorferi. Scientists at Colorado State University (Fort Collins, CO; USA) and their colleagues applied an unbiased metabolomics approach with sera retrospectively obtained from well-characterized patients; they defined biochemical and diagnostic differences between early Lyme disease and STARI.

The investigators used mass spectrometry to identify biomarkers of metabolic differences in the two diseases. Specifically, the team found a metabolic biosignature consisting of 261 molecular features (MFs) that revealed altered N-acyl ethanolamine and primary fatty acid amide metabolism discriminated early Lyme disease from STARI. Development of classification models with the 261-MF biosignature and testing against validation samples differentiated early Lyme disease from STARI with an accuracy of 85% to 98%.

John T. Belisle, PhD, a professor and lead investigator of the study, said, “We were able to tell the difference between early Lyme disease and Southern Tick-Associated Rash Illness by using biomarkers that show us how the body reacts to these illnesses. This could be important in helping to more accurately detect early Lyme disease, which is crucial because the longer people wait for Lyme disease treatment, the higher the potential risk for having more severe symptoms.” The study was published on August 16, 2017, in the journal Science Translational Medicine.

Related Links:
Colorado State University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.